Medica associates with Tom Cherian’s SALi to create ‘Centre for Liver Disease’

IMT News Desk
IMT News Desk
· 3 min read
Medica
Dr. Alok Roy, Chairman Medica Group of Hospitals along with Prof. Dr. Tom Cherian, founder of South Asian Liver Institute(SALi) and Dr. Pradeepta Kumar Sethy, Director of Gastroenterology, and renowned singer Usha Uthup at the launch of Medica Centre for Liver Disease

Kolkata, August 24, 2019: Kolkata headquartered Medica Hospitals has launched the ‘Medica Centre for Liver Disease’ in association with the renowned South Asian Liver Institute (SALi), a Tom Cherian initiative.

The founder Prof. Dr. Tom Cherian was previously the National Director of HPB Surgery & Liver Transplantation, in one of India’s largest hospital chains. He currently continues to be the Professor of Transplant surgery at the prestigious Nizam’s Institute of Medical Sciences (NIMS), in Hyderabad, having started the liver transplant programme there. He had completed over 400 liver transplants in England before his return to India, where he has completed a further 250 transplants.  Most importantly Prof Tom Cherian & his team have over the last 5 years achieved over 90% survival for their transplant recipients. These outcomes are comparable to the results from the best liver units in the world. Moreover in the last 50 liver resections Prof Tom Cherian has done for liver cancers, their mortality or death rate was amongst the least, despite the fact that they have performed some of the most complex liver cancer resections in the country. 

Medica Centre for Liver Disease aims to meet a growing requirement for treatment of liver conditions, including transplant, in Eastern India. The Centre is equipped to handle most diseases of liver, pancreas and gall bladder. Medica’s liver transplant program will involve both living and cadaver donors. Medica is amongst a very few hospitals in the region with comprehensive facilities for treatment of complex liver diseases transplant surgery.

This is a great addition to the existing liver disease management team at Medica, led by the experienced Gastroenterologist & Hepatologist Dr Pradeepta Kumar Sethy, Director of Gastroenterology, Medica Superspecialty Hospital. “It is indeed a timely decision to come up with the Centre for Liver Diseases. No doubt, we can have a focussed holistic approach in dealing with patients suffering from such ailments and diseases,” said Dr Sethy. 

Talking about The Medica Centre for Liver Disease, Prof (Dr.) Tom Cherian, Founder, South Asian Liver Institute (SALi) said “We want to try and make the treatment of liver disease, WORLD CLASS. And what is world class? It simply means there must be no difference in the treatment of a patient with liver disease between Kolkata & London. I promise to make every treatment that I used to perform in London for liver disease, eventually available here in Kolkata! We have already treated several patients from Kolkata, who are doing well and back in the city now, but had to travel far previously for their treatment. I am glad we are able to bring this treatment to this great city, which deserves a superb liver service.” 

Dr. Alok Roy, Chairman, Medica Group of Hospitals said, “This Centre for Liver Diseases is a huge step, and I believe, this is a milestone not only in Kolkata and Bengal but also in Eastern India as a whole. We have a fantastic team of doctors, surgeons, and infrastructure to deal with liver diseases and associated complications.”

Read Next

Apollo Hospitals Brings Advanced Super Speciality Care in Dadar
News
May 11, 2026

Apollo Hospitals Brings Advanced Super Speciality Care in Dadar

Apollo Hospitals has launched its Super Speciality Center in Dadar, bringing advanced medical care to the heart of Mumbai. The Centre offers super-speciality services across Cardiology, Neurology, Oncology, Gastroenterology, Orthopaedics, Transplantation and Pulmonology, supported by comprehensive diagnostics, robotics-enabled care, and 24×7 clinical access. Nearly 8,000 patients from Mumbai travel to Apollo Hospitals Navi Mumbai every […]
Article by: IMT News Desk
ICMR Invites Pharma Industry To Commercialise Indigenous Cervical Cancer Drug Candidate SHetA2
News
May 11, 2026

ICMR Invites Pharma Industry To Commercialise Indigenous Cervical Cancer Drug Candidate SHetA2

In a major boost to India’s fight against cervical cancer, the Indian Council of Medical Research (ICMR) has invited pharmaceutical companies and eligible organisations to partner in the development and commercialisation of an indigenous cervical cancer drug candidate, SHetA2, designed to treat HPV-induced cervical dysplasia and cervical cancer. ICMR has issued an Expression of Interest […]
Article by: IMT News Desk
Bodywell Ayurveda Earns Global Recognition Through Regulatory Compliance and Strategic Expansion
News
May 11, 2026

Bodywell Ayurveda Earns Global Recognition Through Regulatory Compliance and Strategic Expansion

Homegrown Ayurvedic brand Bodywell Ayurveda is announcing a series of milestones that position it as a regulatory-compliant player on the global wellness stage, built on years of operating within India’s stringent regulatory framework. The company, which holds valid Ayurveda and food manufacturing licences in full compliance with national regulatory standards, is now stocked in over […]
Article by: IMT News Desk
AIIMS Launches Low-Cost Advanced Test to Make Epilepsy Treatment Safer
News
May 11, 2026

AIIMS Launches Low-Cost Advanced Test to Make Epilepsy Treatment Safer

The All India Institute of Medical Sciences (AIIMS) has launched an advanced blood testing service that enables doctors to more accurately treat epilepsy patients and reduce the risk of medicine-related side effects. The new facility at AIIMS’ Neurosciences Centre will monitor the levels of two commonly used anti-epilepsy medicines, levetiracetam and lamotrigine, in a patient’s […]
Article by: IMT News Desk